The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Moderna intends to use the above-mentioned funds to support the late-stage development of mRNA-1018, its investigational pandemic influenza vaccine against H5 and H7 avian influenza viruses.

The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...